325 related articles for article (PubMed ID: 24810993)
1. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
[TBL] [Abstract][Full Text] [Related]
2. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and predictors of clinical T1 renal mass (cT1) upstaged to pathological T3a (pT3a) after partial nephrectomy: A single-center experience.
Pathak N; Ganpule A; Patel D; Singh A; Shete N; Sabnis R; Desai M
Int J Urol; 2024 Mar; 31(3):252-257. PubMed ID: 38124339
[TBL] [Abstract][Full Text] [Related]
4. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.
Salmasi A; Faiena I; Lenis AT; Pooli A; Johnson DC; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
Urol Oncol; 2018 Dec; 36(12):527.e13-527.e19. PubMed ID: 30228094
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
6. Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.
Pruthi DK; Miller G; Ankerst DP; Neumair M; Capitanio U; Correa AF; Lane BR; Roussel E; McGregor TB; Derweesh IH; Cordeiro M; Pierorazio PM; Calvo C; Bi H; Noyes SL; Meagher M; Kutikov A; Uzzo RG; Van Poppel H; Larcher A; Montorsi F; Kattan MW; Kaushik D; Liss MA
J Urol; 2023 Nov; 210(5):750-762. PubMed ID: 37579345
[TBL] [Abstract][Full Text] [Related]
7. RENAL nephrometry score predicts surgery type independent of individual surgeon's use of nephron-sparing surgery.
Tobert CM; Kahnoski RJ; Thompson DE; Anema JG; Kuntzman RS; Lane BR
Urology; 2012 Jul; 80(1):157-61. PubMed ID: 22626579
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
9. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
[TBL] [Abstract][Full Text] [Related]
10. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
[TBL] [Abstract][Full Text] [Related]
11. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
12. Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the R.E.N.A.L. Nephrometry Scoring System.
Shin SJ; Ko KJ; Kim TS; Ryoo HS; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
PLoS One; 2015; 10(11):e0141709. PubMed ID: 26599436
[TBL] [Abstract][Full Text] [Related]
13. Pathologic upstaging after laparoscopic radical nephrectomy.
Goel MC; Mohammadi Y; Sethi AS; Brown JA; Sundaram CP
J Endourol; 2008 Oct; 22(10):2257-61. PubMed ID: 18937590
[TBL] [Abstract][Full Text] [Related]
14. R.E.N.A.L. Score Outperforms PADUA Score, C-Index and DAP Score for Outcome Prediction of Nephron Sparing Surgery in a Selected Cohort.
Borgmann H; Reiss AK; Kurosch M; Filmann N; Frees S; Mager R; Tsaur I; Haferkamp A
J Urol; 2016 Sep; 196(3):664-71. PubMed ID: 27091569
[TBL] [Abstract][Full Text] [Related]
15. Prognostic features of upstaged pT3a renal tumors with fat invasion after robot-assisted partial nephrectomy: is it time for a new subclassification?
Di Maida F; Campi R; Grosso AA; Lambertini L; Cadenar A; Giudici S; Pecoraro A; Mari A; Serni S; Minervini A;
Eur J Surg Oncol; 2023 Apr; 49(4):862-867. PubMed ID: 36528511
[TBL] [Abstract][Full Text] [Related]
16. Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates.
Lane BR; Golan S; Eggener S; Tobert CM; Kahnoski RJ; Kutikov A; Smaldone M; Whelan CM; Shalhav A; Uzzo RG
J Urol; 2013 Jun; 189(6):2047-53. PubMed ID: 23313207
[TBL] [Abstract][Full Text] [Related]
17. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.
Ghanie A; Formica MK; Wang D; Bratslavsky G; Stewart T
Int Urol Nephrol; 2018 Feb; 50(2):237-245. PubMed ID: 29247309
[TBL] [Abstract][Full Text] [Related]
18. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
[TBL] [Abstract][Full Text] [Related]
19. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
[TBL] [Abstract][Full Text] [Related]
20. Renal lesions with low R.E.N.A.L nephrometry score are associated with more indolent renal cell carcinomas (RCCs) or benign histology: findings in an Australian cohort.
Satasivam P; Sengupta S; Rajarubendra N; Chia PH; Munshey A; Bolton D
BJU Int; 2012 Apr; 109 Suppl 3():44-7. PubMed ID: 22458493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
